Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Td and PCV13 Concomitant Vaccination in Adults ≥ 50
NCT03552445Phase 4Completed
- Sponsor
- Korea University Guro Hospital
- Start
- Nov 2013
- Primary completion
- Apr 2016
- Modality
- Recombinant Proteins and Enzymes, Split/Subunit Vaccines
01
Overview
A Phase 4 trial of tetanus and diphtheria toxoids adsorbed, pneumococcal 13-valent conjugate vaccine in Tetanus, diphtheria, pneumococcal infection, sponsored by Korea University Guro Hospital. Started Nov 2013; status: completed.
02
Drugs
tetanus and diphtheria toxoids adsorbedpneumococcal 13-valent conjugate vaccine
03
Conditions
Tetanusdiphtheriapneumococcal infection
Beyond the preview
Go deeper on NCT03552445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03552445.